Affiliation:
1. Veterans Affairs Palo Alto Healthcare System Palo Alto CA USA
2. Division of Cardiovascular Medicine Stanford University School of Medicine, and Cardiovascular Institute Stanford CA USA
3. Health Economics Resource Center (HERC), VA Palo Alto Healthcare System Palo Alto CA USA
4. Stanford‐Surgery Policy Improvement Research & Education Center (S‐SPIRE) Stanford Medicine Palo Alto CA USA
5. Department of Medicine Stanford School of Medicine Stanford CA USA
6. Center for Digital Health Stanford University Stanford CA USA
Abstract
Background
Cardiovascular procedural treatments were deferred at scale during the COVID‐19 pandemic, with unclear impact on patients presenting with non–ST‐segment–elevation myocardial infarction (NSTEMI).
Methods and Results
In a retrospective cohort study of all patients diagnosed with NSTEMI in the US Veterans Affairs Healthcare System from January 1, 2019 to October 30, 2022 (n=67 125), procedural treatments and outcomes were compared between the prepandemic period and 6 unique pandemic phases: (1) acute phase, (2) community spread, (3) first peak, (4) post vaccine, (5) second peak, and (6) recovery. Multivariable regression analysis was performed to assess the association between pandemic phases and 30‐day mortality. NSTEMI volumes dropped significantly with the pandemic onset (62.7% of prepandemic peak) and did not revert to prepandemic levels in subsequent phases, even after vaccine availability. Percutaneous coronary intervention and coronary artery bypass grafting volumes declined proportionally. Compared with the prepandemic period, patients with NSTEMI experienced higher 30‐day mortality during Phases 2 and 3, even after adjustment for COVID‐19‐positive status, demographics, baseline comorbidities, and receipt of procedural treatment (adjusted odds ratio for Phases 2 and 3 combined, 1.26 [95% CI, 1.13–1.43],
P
<0.01). Patients receiving Veterans Affairs‐paid community care had a higher adjusted risk of 30‐day mortality compared with those at Veterans Affairs hospitals across all 6 pandemic phases.
Conclusions
Higher mortality after NSTEMI occurred during the initial spread and first peak of the pandemic but resolved before the second, higher peak—suggesting effective adaptation of care delivery but a costly delay to implementation. Investigation into the vulnerabilities of the early pandemic spread are vital to informing future resource‐constrained practices.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Veterans Health Administration–Office of Emergency Management
. COVID‐19 Response Plan. Accessed June 2 2020. https://www.va.gov/opa/docs/VHA_COVID_19_03232020_vF_1.pdf.
2. Centers for Disease Control and Prevention
. Managing Healthcare Operations during COVID‐19. Accessed January 12 2022. https://www.cdc.gov/coronavirus/2019‐ncov/healthcare‐facilities/guidance‐hcf.html.
3. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
4. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
5. Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献